The non-canonical NF-κB pathway in immunity and inflammation

[1]  W. Stohl.  Inhibition of B cell activating factor (BAFF) in the management of systemic lupus erythematosus (SLE) , 2017, Expert review of clinical immunology.

[2]  L. Rui,et al.  A small‐molecule inhibitor of NF‐κB‐inducing kinase (NIK) protects liver from toxin‐induced inflammation, oxidative stress, and injury , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  G. Victora,et al.  Germinal Center B Cell Dynamics. , 2016, Immunity.

[4]  R. Baum,et al.  Bone as a Target Organ in Rheumatic Disease: Impact on Osteoclasts and Osteoblasts , 2016, Clinical Reviews in Allergy & Immunology.

[5]  U. Klein,et al.  Transcription factors of the alternative NF-κB pathway are required for germinal center B-cell development , 2016, Proceedings of the National Academy of Sciences.

[6]  M. Sánchez-Niño,et al.  Non-canonical NFκB activation promotes chemokine expression in podocytes , 2016, Scientific Reports.

[7]  J. Haines,et al.  GWAS analysis implicates NF-κB-mediated induction of inflammatory T cells in multiple sclerosis , 2016, Genes and Immunity.

[8]  Hongbo Hu,et al.  Ubiquitin signaling in immune responses , 2016, Cell Research.

[9]  U. Klein,et al.  Impairment of Mature B Cell Maintenance upon Combined Deletion of the Alternative NF-κB Transcription Factors RELB and NF-κB2 in B Cells , 2016, The Journal of Immunology.

[10]  A. Waisman,et al.  NF‐κB‐inducing kinase is essential for B‐cell maintenance in mice , 2016, European journal of immunology.

[11]  Lawren C. Wu,et al.  Cell intrinsic role of NF-κB-inducing kinase in regulating T cell-mediated immune and autoimmune responses , 2016, Scientific Reports.

[12]  Y. Hamazaki,et al.  Relb acts downstream of medullary thymic epithelial stem cells and is essential for the emergence of RANK+ medullary epithelial progenitors , 2016, European journal of immunology.

[13]  J. Unternaehrer,et al.  Chimeric Vaccine Stimulation of Human Dendritic Cell Indoleamine 2, 3-Dioxygenase Occurs via the Non-Canonical NF-κB Pathway , 2016, PloS one.

[14]  M. Gonzalez-Gaitan,et al.  ESCRT proteins restrict constitutive NF-κB signaling by trafficking cytokine receptors , 2016, Science Signaling.

[15]  D. Vaux,et al.  TRAF2 regulates TNF and NF-κB signalling to suppress apoptosis and skin inflammation independently of Sphingosine kinase 1 , 2015, eLife.

[16]  B. Becher,et al.  The NFκB-inducing kinase is essential for the developmental programming of skin-resident and IL-17-producing γδ T cells , 2015, eLife.

[17]  Mithu Guha,et al.  A highly conserved NF‐κB‐responsive enhancer is critical for thymic expression of Aire in mice , 2015, European journal of immunology.

[18]  J. Inoue,et al.  Visualization of RelB expression and activation at the single-cell level during dendritic cell maturation in Relb-Venus knock-in mice. , 2015, Journal of biochemistry.

[19]  Wei Wei,et al.  The role of BAFF in the progression of rheumatoid arthritis. , 2015, Cytokine.

[20]  Shao-Cong Sun,et al.  NF-κB in inflammation and renal diseases , 2015, Cell & Bioscience.

[21]  I. Mellman,et al.  Dendritic cells require NIK for CD40-dependent cross-priming of CD8+ T cells , 2015, Proceedings of the National Academy of Sciences.

[22]  R. H. Moy,et al.  Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity , 2015, The Journal of experimental medicine.

[23]  P. Tak,et al.  Nuclear Factor-κB–inducing Kinase Is Expressed in Synovial Endothelial Cells in Patients with Early Arthritis and Correlates with Markers of Inflammation: A Prospective Cohort Study , 2015, The Journal of Rheumatology.

[24]  M. Balázs,et al.  Conditional Deletion of NF-κB–Inducing Kinase (NIK) in Adult Mice Disrupts Mature B Cell Survival and Activation , 2015, The Journal of Immunology.

[25]  B. Becher,et al.  Alternative NF‐κB signaling regulates mTEC differentiation from podoplanin‐expressing precursors in the cortico‐medullary junction , 2015, European journal of immunology.

[26]  S. Grey,et al.  Nuclear factor κB–inducing kinase activation as a mechanism of pancreatic β cell failure in obesity , 2015, The Journal of experimental medicine.

[27]  Rebecca Liu,et al.  Complement membrane attack complexes activate noncanonical NF-κB by forming an Akt+NIK+ signalosome on Rab5+ endosomes , 2015, Proceedings of the National Academy of Sciences.

[28]  P. Tak,et al.  Tertiary Lymphoid Structures in Rheumatoid Arthritis: NF-κB-Inducing Kinase-Positive Endothelial Cells as Central Players. , 2015, The American journal of pathology.

[29]  E. Shin,et al.  CD8α(-) Dendritic Cells Induce Antigen-Specific T Follicular Helper Cells Generating Efficient Humoral Immune Responses. , 2015, Cell reports.

[30]  M. Bertrand,et al.  NIK promotes tissue destruction independently of the alternative NF-κB pathway through TNFR1/RIP1-induced apoptosis , 2015, Cell Death and Differentiation.

[31]  S. Basak,et al.  Stimulus-selective crosstalk via the NF-κB signaling system reinforces innate immune response to alleviate gut infection , 2015, eLife.

[32]  J. Caamaño,et al.  NF‐κB1, NF‐κB2 and c‐Rel differentially regulate susceptibility to colitis‐associated adenoma development in C57BL/6 mice , 2015, The Journal of pathology.

[33]  P. Tak,et al.  Non-canonical NF-κB signaling in rheumatoid arthritis: Dr Jekyll and Mr Hyde? , 2015, Arthritis Research & Therapy.

[34]  J. Drouin,et al.  Mutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficiencies , 2014, BMC Medical Genetics.

[35]  Liang Sheng,et al.  Mouse hepatocyte overexpression of NF‐κB‐inducing kinase (NIK) triggers fatal macrophage‐dependent liver injury and fibrosis , 2014, Hepatology.

[36]  G. Superti-Furga,et al.  Biallelic loss-of-function mutation in NIK causes a primary immunodeficiency with multifaceted aberrant lymphoid immunity , 2014, Nature Communications.

[37]  M. Field,et al.  Autosomal-dominant B-cell deficiency with alopecia due to a mutation in NFKB2 that results in nonprocessable p100. , 2014, Blood.

[38]  Kejian Zhang,et al.  Combined Immune Deficiency in a Patient with a Novel NFKB2 Mutation , 2014, Journal of Clinical Immunology.

[39]  P. Tak,et al.  NF-κB-inducing kinase is a key regulator of inflammation-induced and tumour-associated angiogenesis , 2014, The Journal of pathology.

[40]  Shao-Cong Sun,et al.  T Cell–Intrinsic Function of the Noncanonical NF-κB Pathway in the Regulation of GM-CSF Expression and Experimental Autoimmune Encephalomyelitis Pathogenesis , 2014, The Journal of Immunology.

[41]  B. Clark,et al.  Novel NFKB2 Mutation in Early-Onset CVID , 2014, Journal of Clinical Immunology.

[42]  Frédérick A. Mallette,et al.  Noncanonical NF-κB pathway controls the production of type I interferons in antiviral innate immunity. , 2014, Immunity.

[43]  M. Okabe,et al.  Significant involvement of nuclear factor‐κB‐inducing kinase in proper differentiation of αβ and γδ T cells , 2014, Immunology.

[44]  L. Xing,et al.  Chloroquine reduces osteoclastogenesis in murine osteoporosis by preventing TRAF3 degradation. , 2014, The Journal of clinical investigation.

[45]  M. Sánchez-Niño,et al.  TWEAK/Fn14 and Non-Canonical NF-kappaB Signaling in Kidney Disease , 2013, Front. Immunol..

[46]  Emily M. Coonrod,et al.  Germline mutations in NFKB2 implicate the noncanonical NF-κB pathway in the pathogenesis of common variable immunodeficiency. , 2013, American journal of human genetics.

[47]  Susan E. Murray,et al.  A Cell-Intrinsic Requirement for NF-κB–Inducing Kinase in CD4 and CD8 T Cell Memory , 2013, The Journal of Immunology.

[48]  Susan E. Murray,et al.  Cell-Intrinsic Role for NF-kappa B-Inducing Kinase in Peripheral Maintenance but Not Thymic Development of Foxp3+ Regulatory T Cells in Mice , 2013, PloS one.

[49]  J. Goverman,et al.  Modeling the heterogeneity of multiple sclerosis in animals. , 2013, Trends in immunology.

[50]  Heinrich Sticht,et al.  Noncanonical NF-κB Activation by the Oncoprotein Tio Occurs Through a Nonconserved TRAF3-Binding Motif , 2013, Science Signaling.

[51]  G. Trinchieri,et al.  The pivotal role of IKKα in the development of spontaneous lung squamous cell carcinomas. , 2013, Cancer cell.

[52]  R. Goldszmid,et al.  Abstract 1083: The pivotal role of IKKalpha in the development of spontaneous lung squamous cell carcinomas. , 2013 .

[53]  G. Hammer,et al.  Molecular control of steady-state dendritic cell maturation and immune homeostasis. , 2013, Annual review of immunology.

[54]  M. Thome.  Faculty Opinions recommendation of OTUD7B controls non-canonical NF-κB activation through deubiquitination of TRAF3. , 2013 .

[55]  F. Kronenberg,et al.  Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus , 2013, Nature Medicine.

[56]  R. Nelson,et al.  Inflammation: Mechanisms, Costs, and Natural Variation , 2012 .

[57]  Adam R. Johnson,et al.  The crystal structure of the catalytic domain of the NF-κB inducing kinase reveals a narrow but flexible active site. , 2012, Structure.

[58]  A. Hoffmann,et al.  Control of RelB during dendritic cell activation integrates canonical and non-canonical NF-κB pathways , 2012, Nature Immunology.

[59]  N. Bhardwaj,et al.  Activation of the noncanonical NF-κB pathway by HIV controls a dendritic cell immunoregulatory phenotype , 2012, Proceedings of the National Academy of Sciences.

[60]  X. Li,et al.  OX40 signaling favors the induction of TH9 cells and airway inflammation , 2012, Nature Immunology.

[61]  Andrea Rückle,et al.  The NS1 Protein of Influenza A Virus Blocks RIG-I-Mediated Activation of the Noncanonical NF-κB Pathway and p52/RelB-Dependent Gene Expression in Lung Epithelial Cells , 2012, Journal of Virology.

[62]  M. Belich,et al.  Coordinate Regulation of TPL-2 and NF-κB Signaling in Macrophages by NF-κB1 p105 , 2012, Molecular and Cellular Biology.

[63]  N. Walker,et al.  Structure of the Nuclear Factor κB-inducing Kinase (NIK) Kinase Domain Reveals a Constitutively Active Conformation , 2012, The Journal of Biological Chemistry.

[64]  H. Herfarth,et al.  NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. , 2012, Immunity.

[65]  L. Rui,et al.  NF-κB-inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action , 2012, Nature Medicine.

[66]  T. Mak,et al.  Opposing Roles for TRAF1 in the Alternative versus Classical NF-κB Pathway in T Cells* , 2012, The Journal of Biological Chemistry.

[67]  J. Rehg,et al.  NIK Prevents the Development of Hypereosinophilic Syndrome-like Disease in Mice Independent of IKKα Activation , 2012, The Journal of Immunology.

[68]  J. Gommerman,et al.  Fine-tuning of dendritic cell biology by the TNF superfamily , 2012, Nature Reviews Immunology.

[69]  Shao-Cong Sun.  The noncanonical NF‐κB pathway , 2012, Immunological reviews.

[70]  B. Kwon,et al.  Targeting TNF superfamily members for therapeutic intervention in rheumatoid arthritis. , 2012, Cytokine.

[71]  I. Verma,et al.  IKK biology , 2012, Immunological reviews.

[72]  Susan E. Murray,et al.  NF-κB–inducing kinase plays an essential T cell–intrinsic role in graft-versus-host disease and lethal autoimmunity in mice. , 2011, The Journal of clinical investigation.

[73]  V. Jala,et al.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. , 2011, Immunity.

[74]  K. McCoy,et al.  Mice overexpressing BAFF develop a commensal flora-dependent, IgA-associated nephropathy. , 2011, The Journal of clinical investigation.

[75]  J. Caamaño,et al.  Induction of the Alternative NF-κB Pathway by Lymphotoxin αβ (LTαβ) Relies on Internalization of LTβ Receptor , 2011, Molecular and Cellular Biology.

[76]  B. Becher,et al.  NIK signaling in dendritic cells but not in T cells is required for the development of effector T cells and cell-mediated immune responses , 2011, The Journal of experimental medicine.

[77]  S. Choudhary,et al.  NF-kappaB-inducing kinase (NIK) mediates skeletal muscle insulin resistance: blockade by adiponectin. , 2011, Endocrinology.

[78]  Hongbo Hu,et al.  Noncanonical NF-κB regulates inducible costimulator (ICOS) ligand expression and T follicular helper cell development , 2011, Proceedings of the National Academy of Sciences.

[79]  D. Vaux,et al.  Deletion of cIAP1 and cIAP2 in murine B lymphocytes constitutively activates cell survival pathways and inactivates the germinal center response. , 2011, Blood.

[80]  S. Shoelson,et al.  Type 2 diabetes as an inflammatory disease , 2011, Nature Reviews Immunology.

[81]  M. Schmidt-Supprian,et al.  NIK Stabilization in Osteoclasts Results in Osteoporosis and Enhanced Inflammatory Osteolysis , 2010, PloS one.

[82]  R. Mebius,et al.  New insights into the development of lymphoid tissues , 2010, Nature Reviews Immunology.

[83]  G. Tsokos,et al.  T cells as therapeutic targets in SLE , 2010, Nature Reviews Rheumatology.

[84]  G. Cheng,et al.  Negative Feedback in Noncanonical NF-κB Signaling Modulates NIK Stability Through IKKα-Mediated Phosphorylation , 2010, Science Signaling.

[85]  C. Ware,et al.  Allosteric Regulation of the Ubiquitin:NIK and Ubiquitin:TRAF3 E3 Ligases by the Lymphotoxin-β Receptor* , 2010, The Journal of Biological Chemistry.

[86]  S. Nedospasov,et al.  Lymphotoxin beta receptor signaling in intestinal epithelial cells orchestrates innate immune responses against mucosal bacterial infection. , 2010, Immunity.

[87]  W. Paul,et al.  Mechanisms Underlying Lineage Commitment and Plasticity of Helper CD4+ T Cells , 2010, Science.

[88]  M. Sánchez-Niño,et al.  TWEAK Activates the Non-Canonical NFκB Pathway in Murine Renal Tubular Cells: Modulation of CCL21 , 2010, PloS one.

[89]  M. Linterman,et al.  Signals that influence T follicular helper cell differentiation and function , 2010, Seminars in Immunopathology.

[90]  L. Xing,et al.  NF-kappaB p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. , 2009, The Journal of clinical investigation.

[91]  Shan Li,et al.  A Legionella type IV effector activates the NF-κB pathway by phosphorylating the IκB family of inhibitors , 2009, Proceedings of the National Academy of Sciences.

[92]  Shao-Cong Sun,et al.  Regulation of Th17 cell differentiation and EAE induction by MAP3K NIK. , 2009, Blood.

[93]  M. Croft.  The role of TNF superfamily members in T-cell function and diseases , 2009, Nature Reviews Immunology.

[94]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[95]  J. Keats,et al.  Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling , 2008, Nature Immunology.

[96]  T. Mak,et al.  Activation of noncanonical NF-κB requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2, TRAF3 and the kinase NIK , 2008, Nature Immunology.

[97]  H. Takayanagi,et al.  The tumor necrosis factor family receptors RANK and CD40 cooperatively establish the thymic medullary microenvironment and self-tolerance. , 2008, Immunity.

[98]  S. Fischer,et al.  IKKalpha is required to maintain skin homeostasis and prevent skin cancer. , 2008, Cancer cell.

[99]  Kui Li,et al.  Respiratory Syncytial Virus Induces RelA Release from Cytoplasmic 100-kDa NF-κB2 Complexes via a Novel Retinoic Acid-inducible Gene-I·NF-κB-inducing Kinase Signaling Pathway* , 2008, Journal of Biological Chemistry.

[100]  S. Nishikawa,et al.  NIK overexpression amplifies, whereas ablation of its TRAF3-binding domain replaces BAFF:BAFF-R-mediated survival signals in B cells , 2008, Proceedings of the National Academy of Sciences.

[101]  M. Petri,et al.  Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. , 2008, Arthritis and rheumatism.

[102]  Burkhard Becher,et al.  Dendritic Cells Require the NF-κB2 Pathway for Cross-Presentation of Soluble Antigens1 , 2008, The Journal of Immunology.

[103]  F. Mackay,et al.  TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. , 2008, Immunity.

[104]  G. Cheng,et al.  Control of canonical NF-κB activation through the NIK–IKK complex pathway , 2008, Proceedings of the National Academy of Sciences.

[105]  S. Ghosh,et al.  Shared Principles in NF-κB Signaling , 2008, Cell.

[106]  W. Alexander,et al.  A Novel Mutation in the Nfkb2 Gene Generates an NF-κB2 “Super Repressor”1 , 2007, The Journal of Immunology.

[107]  Vishva M. Dixit,et al.  IAP Antagonists Induce Autoubiquitination of c-IAPs, NF-κB Activation, and TNFα-Dependent Apoptosis , 2007, Cell.

[108]  David L. Vaux,et al.  IAP Antagonists Target cIAP1 to Induce TNFα-Dependent Apoptosis , 2007, Cell.

[109]  P. Tak,et al.  Noncanonical NF-κB signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation , 2007 .

[110]  G. Bishop,et al.  Tumor necrosis factor receptor-associated factor 3 is a critical regulator of B cell homeostasis in secondary lymphoid organs. , 2007, Immunity.

[111]  A. Koch.  The pathogenesis of rheumatoid arthritis. , 2007, American journal of orthopedics.

[112]  D. Hilton,et al.  156 A Novel Mutation in the Nfkb2 Gene Generates an NFκB2 ‘Super Repressor’ , 2007 .

[113]  M. Karin,et al.  Regulation of late B cell differentiation by intrinsic IKKα-dependent signals , 2007, Proceedings of the National Academy of Sciences.

[114]  W. An,et al.  Activation of non-canonical NF-kappaB pathway mediated by STP-A11, an oncoprotein of Herpesvirus saimiri. , 2007, Virology.

[115]  J. Ting,et al.  Cutting Edge: Monarch-1 Suppresses Non-Canonical NF-κB Activation and p52-Dependent Chemokine Expression in Monocytes1 , 2007, The Journal of Immunology.

[116]  C. Ware,et al.  NF-kappaB2 is required for the establishment of central tolerance through an Aire-dependent pathway. , 2006, The Journal of clinical investigation.

[117]  S. Gerondakis,et al.  Unravelling the complexities of the NF-κB signalling pathway using mouse knockout and transgenic models , 2006, Oncogene.

[118]  E. Dejardin.  The alternative NF-kappaB pathway from biochemistry to biology: pitfalls and promises for future drug development. , 2006, Biochemical pharmacology.

[119]  G. Cheng,et al.  Rescue of TRAF3-null mice by p100 NF-κB deficiency , 2006, The Journal of experimental medicine.

[120]  C. Jinks,et al.  Disabling knee pain – another consequence of obesity: Results from a prospective cohort study , 2006, BMC public health.

[121]  S. Kaneko,et al.  Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis , 2006, Proceedings of the National Academy of Sciences.

[122]  Shao-Cong Sun,et al.  β-TrCP binding and processing of NF-κB2/p100 involve its phosphorylation at serines 866 and 870 , 2006 .

[123]  S. Choudhary,et al.  Diabetes-Induced Activation of Canonical and Noncanonical Nuclear Factor-κB Pathways in Renal Cortex , 2006, Diabetes.

[124]  S. Akira,et al.  Essential Role of IκB Kinase α in Thymic Organogenesis Required for the Establishment of Self-Tolerance1 , 2006, The Journal of Immunology.

[125]  A. Hoffmann,et al.  Coordination between NF-kappaB family members p50 and p52 is essential for mediating LTbetaR signals in the development and organization of secondary lymphoid tissues. , 2006, Blood.

[126]  C. Hotta,et al.  Impaired function of dendritic cells in alymphoplasia (aly/aly) mice for expansion of CD25+CD4+ regulatory T cells , 2006, Autoimmunity.

[127]  T. Kawabe,et al.  Helicobacter pylori Activates NF-κB via the Alternative Pathway in B Lymphocytes , 2005, The Journal of Immunology.

[128]  H. Ohno,et al.  Stimulation of CD30 in anaplastic large cell lymphoma leads to production of nuclear factor‐κB p52, which is associated with hyperphosphorylated Bcl‐3 , 2005, Cancer science.

[129]  Osami Kanagawa,et al.  NF-κB–inducing kinase controls lymphocyte and osteoclast activities in inflammatory arthritis , 2005 .

[130]  S. Choudhary,et al.  Respiratory Syncytial Virus Influences NF-κB-Dependent Gene Expression through a Novel Pathway Involving MAP3K14/NIK Expression and Nuclear Complex Formation with NF-κB2 , 2005, Journal of Virology.

[131]  N. Yamamoto,et al.  Aberrant NF-κB2/p52 expression in Hodgkin/Reed–Sternberg cells and CD30-transformed rat fibroblasts , 2005, Oncogene.

[132]  S. Maeda,et al.  Dependence of Self-Tolerance on TRAF6-Directed Development of Thymic Stroma , 2005, Science.

[133]  Shao-Cong Sun,et al.  An Atypical Tumor Necrosis Factor (TNF) Receptor-associated Factor-binding Motif of B Cell-activating Factor Belonging to the TNF Family (BAFF) Receptor Mediates Induction of the Noncanonical NF-κB Signaling Pathway* , 2005, Journal of Biological Chemistry.

[134]  R. Brink,et al.  TRAF2 differentially regulates the canonical and noncanonical pathways of NF-kappaB activation in mature B cells. , 2004, Immunity.

[135]  P. Ramakrishnan,et al.  Receptor-Specific Signaling for Both the Alternative and the Canonical NF-κB Activation Pathways by NF-κB-Inducing Kinase , 2004 .

[136]  J. Caamaño,et al.  A Stroma-Derived Defect in NF-κB2−/− Mice Causes Impaired Lymph Node Development and Lymphocyte Recruitment1 , 2004, The Journal of Immunology.

[137]  S. Tangye,et al.  The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers. , 2004, Current opinion in pharmacology.

[138]  P. Chaudhary,et al.  Activation of alternative NF-κB pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1β-converting enzyme inhibitory protein (vFLIP) , 2004 .

[139]  E. Harhaj,et al.  Regulation of the NF-κB-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation* , 2004, Journal of Biological Chemistry.

[140]  G. Xiao,et al.  Induction of p100 Processing by NF-κB-inducing Kinase Involves Docking IκB Kinase α (IKKα) to p100 and IKKα-mediated Phosphorylation* , 2004, Journal of Biological Chemistry.

[141]  T. Nomura,et al.  NF-κB-Inducing Kinase Establishes Self-Tolerance in a Thymic Stroma-Dependent Manner1 , 2004, The Journal of Immunology.

[142]  E. Kieff,et al.  Epstein–Barr virus latent infection membrane protein 1 TRAF-binding site induces NIK/IKKα-dependent noncanonical NF-κB activation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[143]  T. Saitoh,et al.  TWEAK Induces NF-κB2 p100 Processing and Long Lasting NF-κB Activation* , 2003, Journal of Biological Chemistry.

[144]  J. Caamaño,et al.  Regulation of secondary lymphoid organ development by the nuclear factor‐κB signal transduction pathway , 2003, Immunological reviews.

[145]  L. Yin,et al.  The IκB Function of NF-κB2 p100 Controls Stimulated Osteoclastogenesis , 2003, The Journal of Experimental Medicine.

[146]  T. Banks,et al.  NIK-dependent RelB Activation Defines a Unique Signaling Pathway for the Development of Vα14i NKT Cells , 2003, The Journal of experimental medicine.

[147]  F. Weih,et al.  Differential Requirement for Rel/Nuclear Factor κB Family Members in Natural Killer T Cell Development , 2003, The Journal of experimental medicine.

[148]  F. Weih,et al.  RelB is required for Peyer's patch development: differential regulation of p52–RelB by lymphotoxin and TNF , 2003, The EMBO journal.

[149]  B. Huhse,et al.  CD40 regulates the processing of NF‐κB2 p100 to p52 , 2002 .

[150]  D. Seshasayee,et al.  BAFF/BLyS receptor 3 binds the B cell survival factor BAFF ligand through a discrete surface loop and promotes processing of NF-kappaB2. , 2002, Immunity.

[151]  D. Green,et al.  The Lymphotoxin-β Receptor Induces Different Patterns of Gene Expression via Two NF-κB Pathways , 2002 .

[152]  Hong-shan Wang,et al.  BAFF-induced NEMO-independent processing of NF-κB2 in maturing B cells , 2002, Nature Immunology.

[153]  A. Fong,et al.  Genetic Evidence for the Essential Role of β-Transducin Repeat-containing Protein in the Inducible Processing of NF-κB2/p100* , 2002, The Journal of Biological Chemistry.

[154]  E. Harhaj,et al.  Retroviral oncoprotein Tax induces processing of NF‐κB2/p100 in T cells: evidence for the involvement of IKKα , 2001 .

[155]  Zongyi Hu,et al.  Additive activation of hepatic NF‐κB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF‐α receptor 1‐independent and ‐dependent mechanisms , 2001 .

[156]  Michael Karin,et al.  Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway , 2001, Science.

[157]  F. Weih,et al.  Essential Role of RelB in Germinal Center and Marginal Zone Formation and Proper Expression of Homing Chemokines1 , 2001, The Journal of Immunology.

[158]  E. Harhaj,et al.  NF-κB-Inducing Kinase Regulates the Processing of NF-κB2 p100 , 2001 .

[159]  G. Alarcón,et al.  Cutting Edge: A Role for B Lymphocyte Stimulator in Systemic Lupus Erythematosus1 , 2001, The Journal of Immunology.

[160]  T. Serikawa,et al.  Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase , 1999, Nature Genetics.

[161]  W. Greene,et al.  Cotranslational Biogenesis of NF-κB p50 by the 26S Proteasome , 1998, Cell.

[162]  A. Leonardi,et al.  Mice Deficient in Nuclear Factor (NF)-κB/p52 Present with Defects in Humoral Responses, Germinal Center Reactions, and Splenic Microarchitecture , 1998, The Journal of experimental medicine.

[163]  C. Snapper,et al.  Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses , 1998, The Journal of experimental medicine.

[164]  D. Lo,et al.  Expression of relB is required for the development of thymic medulla and dendritic cells , 1995, Nature.

[165]  F. Weih,et al.  Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family , 1995, Cell.

[166]  W. Greene,et al.  Autoregulation of the NF-kappa B transactivator RelA (p65) by multiple cytoplasmic inhibitors containing ankyrin motifs. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[167]  S. Ikehara,et al.  A new mutation, aly, that induces a generalized lack of lymph nodes accompanied by immunodeficiency in mice , 1994, European journal of immunology.

[168]  M. Claesson,et al.  Thymic Epithelial Cells , 1990, Scandinavian journal of immunology.

[169]  S. Ley,et al.  New insights into NF- κ B regulation and function , 2018 .

[170]  D. Novack.  Role of NF-κB in the skeleton , 2011, Cell Research.

[171]  Shao-Cong Sun,et al.  Non-canonical NF-κB signaling pathway , 2011, Cell Research.

[172]  Carl Nathan,et al.  Nonresolving Inflammation , 2010, Cell.

[173]  A. Israël.  The IKK Complex , a Central Regulator of NFk B Activation , 2010 .

[174]  M. Belich,et al.  Proteolysis of NF-κB1 p105 is essential for T cell antigen receptor–induced proliferation , 2009, Nature Immunology.

[175]  M. Karin,et al.  Regulation of late B cell differentiation by intrinsic IKKalpha-dependent signals. , 2007, Proceedings of the National Academy of Sciences of the United States of America.

[176]  J. Ting,et al.  Monarch-1 suppresses non-canonical NF-kappaB activation and p52-dependent chemokine expression in monocytes. , 2007, Journal of immunology.

[177]  Vinay Tergaonkar,et al.  IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. , 2007, Cell.

[178]  Vishva M Dixit,et al.  IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. , 2007, Cell.

[179]  R. Steinman,et al.  Dendritic cells: translating innate to adaptive immunity. , 2006, Current topics in microbiology and immunology.

[180]  S. Akira,et al.  Essential role of IkappaB kinase alpha in thymic organogenesis required for the establishment of self-tolerance. , 2006, Journal of immunology.

[181]  G. Xiao,et al.  Induction of p100 processing by NF-kappaB-inducing kinase involves docking IkappaB kinase alpha (IKKalpha) to p100 and IKKalpha-mediated phosphorylation. , 2004, The Journal of biological chemistry.

[182]  D. Green,et al.  The lymphotoxin-beta receptor induces different patterns of gene expression via two NF-kappaB pathways. , 2002, Immunity.

[183]  山田 卓司.  Abnormal immune function of hemopoietic cells from alymphoplasia (aly) mice, a natural strain with mutant NF-κB-inducing kinase , 2001 .

[184]  E. Harhaj,et al.  Retroviral oncoprotein Tax induces processing of NF-kappaB2/p100 in T cells: evidence for the involvement of IKKalpha. , 2001, The EMBO journal.

[185]  B. Jaruga,et al.  Additive activation of hepatic NF-kappaB by ethanol and hepatitis B protein X (HBX) or HCV core protein: involvement of TNF-alpha receptor 1-independent and -dependent mechanisms. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[186]  D. Perazzo,et al.  [Systemic lupus erythematosus]. , 1955, Prensa medica argentina.

[187]  S. Akira,et al.  Brief Definitive Report Essential Role of Nuclear Factor (nf)-␬ B–inducing Kinase and Inhibitor of ␬ B (i ␬ B) Kinase ␣ in Nf-␬ B Activation through Lymphotoxin ␤ Receptor, but Not through Tumor Necrosis Factor Receptor I , 2022 .

[188]  Mark S. Anderson,et al.  Br Ief Definitive Repor T Identification of a Novel Cis-regulatory Element Essential for Immune Tolerance , 2022 .